Insulin lispro

Chemical formula: C₂₅₇H₃₈₉N₆₅O₇₇S₆  Molecular mass: 5,811.691 g/mol 

Active ingredient description

The primary activity of insulin lispro is the regulation of glucose metabolism.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A10AB04 Insulin lispro A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB04
A10AC04 Insulin lispro A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
Discover more medicines within A10AC04
A10AD04 Insulin lispro A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
HUMALOG 100 units/ml Solution for injection in vial / Cartridge / KwikPen - Junior KwikPen European Medicines Agency (EU) MPI, EU: SmPC
HUMALOG 200 units/ml Solution for injection KwikPen pre-filled pen European Medicines Agency (EU) MPI, EU: SmPC
ADMELOG Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
HUMALOG Mix50 100 units/ml Suspension for injection in cartridge / KwikPen pre-filled pen European Medicines Agency (EU) MPI, EU: SmPC
HUMALOG Mix25 100 units/ml Suspension for injection in vial / cartridge / KwikPen pre-filled pen European Medicines Agency (EU) MPI, EU: SmPC

External identifiers

CAS Substance: 133107-64-9
DrugBank Drug: DB00046
KEGG Drug: D04477
RxNorm Ingredient: 86009
SNOMED-CT Concept: 412210000
Insulin lispro (substance)
UNII Identifier: GFX7QIS1II
INSULIN LISPRO

Medicines

Insulin lispro is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.